Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myomo (MYO) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Myomo (MYO) over the last 10 years, with Q3 2025 value amounting to -$3.7 million.

  • Myomo's Consolidated Net Income fell 27902.33% to -$3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.0 million, marking a year-over-year decrease of 4300.99%. This contributed to the annual value of -$7.2 million for FY2024, which is 1896.1% up from last year.
  • As of Q3 2025, Myomo's Consolidated Net Income stood at -$3.7 million, which was down 27902.33% from -$4.6 million recorded in Q2 2025.
  • In the past 5 years, Myomo's Consolidated Net Income registered a high of -$966409.0 during Q3 2024, and its lowest value of -$4.6 million during Q2 2025.
  • In the last 5 years, Myomo's Consolidated Net Income had a median value of -$2.8 million in 2022 and averaged -$2.6 million.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first surged by 6513.66% in 2023, then plummeted by 31297.64% in 2025.
  • Myomo's Consolidated Net Income (Quarter) stood at -$2.9 million in 2021, then increased by 20.25% to -$2.3 million in 2022, then tumbled by 35.65% to -$3.2 million in 2023, then skyrocketed by 60.23% to -$1.3 million in 2024, then crashed by 189.16% to -$3.7 million in 2025.
  • Its Consolidated Net Income stands at -$3.7 million for Q3 2025, versus -$4.6 million for Q2 2025 and -$3.5 million for Q1 2025.